KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Liabilities: 2009-2024

Historic Total Liabilities for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • Exact Sciences' Total Liabilities fell 3.94% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 3.94%. This contributed to the annual value of $3.5 billion for FY2024, which is 6.01% up from last year.
  • Latest data reveals that Exact Sciences reported Total Liabilities of $3.5 billion as of FY2024, which was up 6.01% from $3.3 billion recorded in FY2023.
  • In the past 5 years, Exact Sciences' Total Liabilities registered a high of $3.5 billion during FY2024, and its lowest value of $2.7 billion during FY2020.
  • For the 3-year period, Exact Sciences' Total Liabilities averaged around $3.3 billion, with its median value being $3.3 billion (2023).
  • As far as peak fluctuations go, Exact Sciences' Total Liabilities skyrocketed by 120.87% in 2020, and later decreased by 3.44% in 2022.
  • Yearly analysis of 5 years shows Exact Sciences' Total Liabilities stood at $2.7 billion in 2020, then grew by 22.60% to $3.3 billion in 2021, then fell by 3.44% to $3.2 billion in 2022, then increased by 4.47% to $3.3 billion in 2023, then climbed by 6.01% to $3.5 billion in 2024.